My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?

    Steck AK, Zhang W, Bugawan TL, Barriga KJ, Blair A, Erlich HA, Eisenbarth GS, Norris JM, Rewers MJ.

    Diabetes. 2009 Apr;58(4):1028-33. Epub 2009 Feb 2.PMID: 19188433 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.

    Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Rønningen KS, Stene LC.

    Diabetologia. 2008 Apr;51(4):589-96. Epub 2008 Feb 22.PMID: 18292987 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.

    Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E.

    Diabetologia. 2003 May;46(5):712-20. Epub 2003 May 16.PMID: 12750767 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes.

    Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M, Ilonen J.

    Diabetologia. 2006 Jun;49(6):1198-208. Epub 2006 Apr 14.PMID: 16614815 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).

    Butty V, Campbell C, Mathis D, Benoist C; DPT-1 Study Group.

    Diabetes. 2008 Sep;57(9):2348-59. Epub 2008 Jun 12.PMID: 18556337 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.

    Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lähde J, Simell O, Knip M, Ilonen J.

    Diabetologia. 2005 Sep;48(9):1766-75. Epub 2005 Jul 16.PMID: 16025255 [PubMed - indexed for MEDLINE]Related articles

    7.

    Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.

    Redondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum C, Palmer JP, Cuthbertson D, Eisenbarth GS, Krischer JP, Schatz D; Diabetes Prevention Trial Type 1 Study Group.

    J Clin Endocrinol Metab. 2006 May;91(5):1705-13. Epub 2006 Feb 7.PMID: 16464953 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.

    Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R.

    Diabetologia. 1999 May;42(5):608-16.PMID: 10333055 [PubMed - indexed for MEDLINE]Related articles

    9.

    Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.

    Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ.

    J Autoimmun. 2005;25 Suppl:40-5. Epub 2005 Oct 19. Review.PMID: 16242305 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of non-HLA genes with type 1 diabetes autoimmunity.

    Steck AK, Bugawan TL, Valdes AM, Emery LM, Blair A, Norris JM, Redondo MJ, Babu SR, Erlich HA, Eisenbarth GS, Rewers MJ.

    Diabetes. 2005 Aug;54(8):2482-6.PMID: 16046318 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

    Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

    Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.PMID: 10707033 [PubMed - indexed for MEDLINE]Related articles

    12.

    Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

    Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.

    Clin Exp Immunol. 1999 Apr;116(1):78-83.PMID: 10209508 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.

    Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.

    Diabetologia. 2002 Jan;45(1):66-76.PMID: 11845225 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry.

    van der Auwera B, Schuit F, Lyaruu I, Falorni A, Svanholm S, Vandewalle CL, Gorus FK.

    J Clin Endocrinol Metab. 1995 Sep;80(9):2567-73.PMID: 7673396 [PubMed - indexed for MEDLINE]Related articles

    15.

    HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population.

    Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS.

    Diabetes. 2007 Sep;56(9):2405-9. Epub 2007 May 18.PMID: 17513705 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.

    Kukko M, Virtanen SM, Toivonen A, Simell S, Korhonen S, Ilonen J, Simel O, Knip M.

    Diabetes Care. 2004 Mar;27(3):676-81.PMID: 14988284 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes.

    Hauache OM, Reis AF, Oliveira CS, Vieira JG, Sjöroos M, Ilonen J.

    Dis Markers. 2005;21(3):139-45.PMID: 16276008 [PubMed - indexed for MEDLINE]Related articles

    18.

    CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.

    Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, Lamberigts G, Gorus FK.

    Clin Exp Immunol. 1997 Oct;110(1):98-103.PMID: 9353155 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.

    Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E.

    Int J Immunogenet. 2008 Apr;35(2):133-40. Epub 2008 Feb 11.PMID: 18279373 [PubMed - indexed for MEDLINE]Related articles

    20.

    Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry.

    Vandewalle CL, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK.

    Diabetes Care. 1997 Oct;20(10):1547-52.PMID: 9314633 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity